Plasma cell-free DNA measured prior to renal replacement therapy initiation is not associated with incident adverse outcomes, hospitalizations or malignancies in chronic kidney disease stage 4–5 patients. - Liuhto, Niilo; Tuominen, Jenni; Manni, Noora; Hakamäki, Markus; Lankinen, Roosa; Toukola, Tomi; Virtanen, Jonna; Metsärinne, Kaj; Järvisalo, Mikko J.; Hellman, Tapio (PLoS ONE, 2026)